The DOI matches its Crossref record; 71 of the 72 references it cites were found in a registry or an index; 23 of the 59 sources its claims cite were checked for support.
Lactiplantibacillus plantarum N4 ameliorates lipid metabolism and gut microbiota structure in high fat diet-fed rats
Open accessAbstract
Lowing blood lipid levels with probiotics has good application prospects. This study aimed to isolate probiotics with hypolipidemic efficacy from homemade na dish and investigate their mechanism of action. In vitro experiments were conducted to determine the cholesterol-lowering ability of five isolates, with results showing that Lactiplantibacillus plantarum N4 exhibited a high cholesterol-lowering rate of 50.27% and significant resistance to acid (87%), bile salt (51.97%), and pepsin (88.28%) in simulated gastrointestinal fluids, indicating promising application prospects for the use of probiotics in lowering blood lipids. The findings from the in vivo experiment demonstrated that the administration of N4 effectively attenuated lipid droplet accumulation and inflammatory cell infiltration in the body weight and liver of hyperlipidemic rats, leading to restoration of liver tissue morphology and structure, as well as improvement in lipid and liver biochemical parameters. 16S analysis indicated that the oral administration of N4 led to significant alterations in the relative abundance of various genera, including Sutterella , Bacteroides , Clostridium , and Ruminococcus , in the gut microbiota of hyperlipidemia rats. Additionally, fecal metabolomic analysis identified a total of 78 metabolites following N4 intervention, with carboxylic acids and their derivatives being the predominant compounds detected. The transcriptomic analysis revealed 156 genes with differential expression following N4 intervention, leading to the identification of 171 metabolic pathways through Kyoto Encyclopedia of Genes and Genomes enrichment analysis. Notably, the glutathione metabolism pathway, PPAR signaling pathway, and bile secretion pathway emerged as the primary enrichment pathways. The findings from a comprehensive multi-omics analysis indicate that N4 influences lipid metabolism and diminishes lipid levels in hyperlipidemic rats through modulation of fumaric acid and γ-aminobutyric acid concentrations, as well as glutathione and other metabolic pathways in the intestinal tract, derived from both the gut microbiota and the host liver. This research offers valuable insights into the therapeutic potential of probiotics for managing lipid metabolism disorders and their utilization in the development of functional foods.
Overview
CoChat Summary
## TL;DR
Lactiplantibacillus plantarum N4 was isolated from fermented na dish and showed strong in vitro cholesterol-lowering and gastrointestinal tolerance properties. In high-fat diet rats, N4 improved serum lipids, liver steatosis, gut microbiota composition, fecal metabolites, and hepatic transcriptomic pathways linked to lipid metabolism.
## Key findings
- Five cholesterol-lowering lactic acid bacterial strains were isolated; N4 had the highest cholesterol degradation rate at 50.27% and was identified as Lpb. plantarum based on 16S rRNA sequencing.
- N4 showed good simulated gastrointestinal tolerance: 87% survival under acidic conditions, 51.97% survival after 3 h in 0.3% bile salts, and 88.28% survival in simulated gastric fluid.
- In hyperlipidemic rats, 8 weeks of N4 significantly reduced serum TC and LDL-C (p < 0.05) and increased HDL-C (p < 0.01); TG did not decrease significantly.
- Multi-omics results reported 78 differential fecal metabolites, 156 differential liver genes, and 171 enriched KEGG pathways; the most prominent pathways included glutathione metabolism, PPAR signaling, and bile secretion.
## Methods
- Design: The study first screened lactic acid bacteria from fermented na dish in vitro, then tested the selected strain in an 8-week rat intervention under high-fat diet conditions.
- Sample/data: The animal study used 32 SD rats aged 5 weeks and weighing about 170 ± 5 g; 6 rats per group were selected for gut microbiota sequencing and fecal metabolomics.
- Analysis: The paper used biochemical assays for serum lipids, H&E liver histology, 16S rRNA gut microbiome sequencing, UPLC-QTOF/MS fecal metabolomics, liver RNA-seq, RT-qPCR validation, and ANOVA/Tukey for statistics.
## Limitations
- The paper states that it did not delve into whether the observed increase in gamma-aminobutyric acid following Lpb. plantarum N4 intervention triggered beige lipid differentiation and its impact on the gut-liver-brain axis.
- Evident from the text: the in vivo work was done in rats, so direct human efficacy is not tested in this paper.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
19 Valid · 3 Not valid · 25 Not checked · 96 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Probiotics modulate lipid metabolism via two key metabolites, short-chain fatty acids (SCFAs) and secondary bile acids (BAs).”
§ Lactiplantibacillus plantarum N4 ameliorates lipid metabolism and gut microbiota structure in high fat diet-fed rats > Introduction Hyperlipidemia constitutes a significant risk factor in the onset of cardiovascular diseases (Stewart et al., 2020). Over recent decades, a plethora of synthetic drugs have emerged for hyperlipidemia management. Nevertheless, clinical evidence supports the occurrence of specific adverse effects associated with most lipid-lowering drugs (Dybiec et al., 2023). Recent studies have underscored the lipid-lowering effects of probiotics. Probiotics modulate lipid metabolism via two key metabolites, short-chain fatty acids (SCFAs) and secondary bile acids (BAs). BAs, pivotal signaling molecules, significantly contribute to fat digestion by emulsifying fats into smaller particles, subsequently broken down into fatty acids by lipoprotein lipase (Yang et al., 2022). SCFAs, beneficial metabolites resulting from probiotic fermentation, primarily encompass acetic, propionic, and butyric acids, which also play an important role in inhibiting cholesterol synthesis. For instance, short-chain fatty acids derived from Lactobacillus strains inhibit cholesterol synthesis by attenuating the activity of DL-3-hydroxy-3-methylglutaryl coenzyme A (HMG-COA) reductase (Tian et al., 2022). Furthermore, research indicates that SCFAs and BAs prompt the secretion of gut hormones implicated in lipid metabolism (Chen et al., 2023). Moreover, certain enzymes and inhibitors generated by probiotics modulate the body’s lipid metabolism, consequently lowering cholesterol levels. For instance, Lactobacillus produces cholesterol dehydrogenase/isomerase, which transforms cholesterol into coprosterol, subsequently expelled from the body through feces (Singhal et al., 2019). Through binding to and stimulating hepatic X receptors, Lactobacillus effectively downregulates host cholesterol synthesis (Ye et al., 2022). Additionally, Lactobacillus induces activation of the Farnesoid X receptor, leading to the downregulation of the expression of key enzymes in bile acid synthesis, namely cholesterol-7α-hydroxylase (CYP7A1) and sterol-12α-hydroxylase (CYP8B1). This modulation ultimately results in decreased cholesterol levels in vivo (Lim et al., 2020). Furthermore, the secretion of bile salt hydrolase (BSH) by Lactobacillus spp. contributes to the reduction in host cholesterol levels by hydrolyzing bound bile acids within the organism, thereby preventing their absorption (Hernández-Gómez et al., 2021). The liver serves as the primary organ for lipid metabolism within the body, functioning as a central hub for various physiological processes. It plays crucial roles in nutrient metabolism, supporting the immune system, controlling endocrine signaling pathways related to growth, maintaining lipid and cholesterol homeostasis, and serving as a key site for glutathione (GSH) metabolism (Trefts et al., 2017). Among these functions, GSH and its related enzymes form an antioxidant defense system that plays a key role in protecting hepatocytes from oxidative stress and other potential injuries (Liu et al., 2021). GSH is a tripeptide containing a γ-amide bond and sulfhydryl group, consisting of glutamic acid, cysteine and glycine. It is an ubiquitous mammalian antioxidant that plays an important role in resistance to oxidative damage, nutrient metabolism, and numerous regulatory cellular events, including gene expression, DNA and protein synthesis, cell proliferation and apoptosis, iron death, signal transduction, cytokine production and immune responses, and protein glutathionylation (Wang et al., 2021; Zhang et al., 2021). Simultaneously, the liver plays a central role in REDOX reactions, thereby contributing substantially to metabolic regulation and safeguarding. Oxidative stress additionally plays a role in the functionality of beige adipose tissue, where adipocytes can chelate succinic acid and oxidize it in the mitochondria, promoting thermogenic respiration (Fuentes et al., 2013). Studies have indicated that specific anti-cancer medications, polysaccharides, and isolated compounds can influence lipid metabolism disorders and gut microbiota composition in rats consuming high-fat diets, primarily through REDOX reactions (Guo et al., 2018; Hu et al., 2021). Recent research indicates that the gut microbiota plays a significant role in modulating the body’s metabolism, thereby influencing the development and advancement of chronic conditions like obesity, diabetes, and atherosclerosis (Hasani et al., 2021). While the hypolipidemic effects of certain probiotic strains are established, further research is needed to fully understand the mechanisms by which probiotics regulate lipid metabolism, as various strains may operate through distinct pathways. Na dish is a traditional local dish from Jiangxi Province in China, which is a plant-based natural fermented food. The primary objective of this research was to isolate potential probiotic strains with excellent cholesterol-lowering capabilities from na dish, particularly Lpb. plantarum N4, and explore its potential therapeutic advantages in alleviating hyperlipidemia. This study entailed evaluating alterations in intestinal microbiota, liver transcriptome, and fecal metabolites to uncover the mechanisms at play. By examining the impact of Lpb. plantarum N4 consumption on intestinal microorganisms and establishing correlations between fecal metabolite profiles and intestinal microbiota, the study aimed to lay the groundwork for developing functional Lactobacillus-based products for the prevention of hyperlipidemia.
What the sources say
- Partly supportedcites Yang et al., 2022 sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) says bile acids play a crucial role in lipid absorption and metabolism. But the cited paper does not establish that probiotics modulate lipid metabolism through SCFAs and secondary bile acids; the passages concern bile-acid supplementation, not probiotics or those two metabolites together. (LLM, conf=0.84)
- Not checked — no full text of the sourcecites Tian et al., 2022 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“research indicates that SCFAs and BAs prompt the secretion of gut hormones implicated in lipid metabolism (Chen et al., 2023).”
§ Lactiplantibacillus plantarum N4 ameliorates lipid metabolism and gut microbiota structure in high fat diet-fed rats > Introduction Hyperlipidemia constitutes a significant risk factor in the onset of cardiovascular diseases (Stewart et al., 2020). Over recent decades, a plethora of synthetic drugs have emerged for hyperlipidemia management. Nevertheless, clinical evidence supports the occurrence of specific adverse effects associated with most lipid-lowering drugs (Dybiec et al., 2023). Recent studies have underscored the lipid-lowering effects of probiotics. Probiotics modulate lipid metabolism via two key metabolites, short-chain fatty acids (SCFAs) and secondary bile acids (BAs). BAs, pivotal signaling molecules, significantly contribute to fat digestion by emulsifying fats into smaller particles, subsequently broken down into fatty acids by lipoprotein lipase (Yang et al., 2022). SCFAs, beneficial metabolites resulting from probiotic fermentation, primarily encompass acetic, propionic, and butyric acids, which also play an important role in inhibiting cholesterol synthesis. For instance, short-chain fatty acids derived from Lactobacillus strains inhibit cholesterol synthesis by attenuating the activity of DL-3-hydroxy-3-methylglutaryl coenzyme A (HMG-COA) reductase (Tian et al., 2022). Furthermore, research indicates that SCFAs and BAs prompt the secretion of gut hormones implicated in lipid metabolism (Chen et al., 2023). Moreover, certain enzymes and inhibitors generated by probiotics modulate the body’s lipid metabolism, consequently lowering cholesterol levels. For instance, Lactobacillus produces cholesterol dehydrogenase/isomerase, which transforms cholesterol into coprosterol, subsequently expelled from the body through feces (Singhal et al., 2019). Through binding to and stimulating hepatic X receptors, Lactobacillus effectively downregulates host cholesterol synthesis (Ye et al., 2022). Additionally, Lactobacillus induces activation of the Farnesoid X receptor, leading to the downregulation of the expression of key enzymes in bile acid synthesis, namely cholesterol-7α-hydroxylase (CYP7A1) and sterol-12α-hydroxylase (CYP8B1). This modulation ultimately results in decreased cholesterol levels in vivo (Lim et al., 2020). Furthermore, the secretion of bile salt hydrolase (BSH) by Lactobacillus spp. contributes to the reduction in host cholesterol levels by hydrolyzing bound bile acids within the organism, thereby preventing their absorption (Hernández-Gómez et al., 2021). The liver serves as the primary organ for lipid metabolism within the body, functioning as a central hub for various physiological processes. It plays crucial roles in nutrient metabolism, supporting the immune system, controlling endocrine signaling pathways related to growth, maintaining lipid and cholesterol homeostasis, and serving as a key site for glutathione (GSH) metabolism (Trefts et al., 2017). Among these functions, GSH and its related enzymes form an antioxidant defense system that plays a key role in protecting hepatocytes from oxidative stress and other potential injuries (Liu et al., 2021). GSH is a tripeptide containing a γ-amide bond and sulfhydryl group, consisting of glutamic acid, cysteine and glycine. It is an ubiquitous mammalian antioxidant that plays an important role in resistance to oxidative damage, nutrient metabolism, and numerous regulatory cellular events, including gene expression, DNA and protein synthesis, cell proliferation and apoptosis, iron death, signal transduction, cytokine production and immune responses, and protein glutathionylation (Wang et al., 2021; Zhang et al., 2021). Simultaneously, the liver plays a central role in REDOX reactions, thereby contributing substantially to metabolic regulation and safeguarding. Oxidative stress additionally plays a role in the functionality of beige adipose tissue, where adipocytes can chelate succinic acid and oxidize it in the mitochondria, promoting thermogenic respiration (Fuentes et al., 2013). Studies have indicated that specific anti-cancer medications, polysaccharides, and isolated compounds can influence lipid metabolism disorders and gut microbiota composition in rats consuming high-fat diets, primarily through REDOX reactions (Guo et al., 2018; Hu et al., 2021). Recent research indicates that the gut microbiota plays a significant role in modulating the body’s metabolism, thereby influencing the development and advancement of chronic conditions like obesity, diabetes, and atherosclerosis (Hasani et al., 2021). While the hypolipidemic effects of certain probiotic strains are established, further research is needed to fully understand the mechanisms by which probiotics regulate lipid metabolism, as various strains may operate through distinct pathways. Na dish is a traditional local dish from Jiangxi Province in China, which is a plant-based natural fermented food. The primary objective of this research was to isolate potential probiotic strains with excellent cholesterol-lowering capabilities from na dish, particularly Lpb. plantarum N4, and explore its potential therapeutic advantages in alleviating hyperlipidemia. This study entailed evaluating alterations in intestinal microbiota, liver transcriptome, and fecal metabolites to uncover the mechanisms at play. By examining the impact of Lpb. plantarum N4 consumption on intestinal microorganisms and establishing correlations between fecal metabolite profiles and intestinal microbiota, the study aimed to lay the groundwork for developing functional Lactobacillus-based products for the prevention of hyperlipidemia.
What the sources say
- Supportedcites Chen et al., 2023 source
The section on mechanisms of SGA-induced lipid disorders says SCFAs and secondary bile acids signal to enteroendocrine cells, resulting in secretion of intestinal hormones. The Figure 2 caption also links these gut hormones to lipid metabolism. (LLM, conf=0.94)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Interestingly, some probiotics are effective in reducing lipid concentrations and lipid deposition in rats fed with a high-fat diet.”
§ Lactiplantibacillus plantarum N4 ameliorates lipid metabolism and gut microbiota structure in high fat diet-fed rats > Discussion
What the sources say
- Not checked — no full text of the sourcecites Yadav et al., 2018 source
- Not checked — no full text of the sourcecites Thakkar et al., 2020 source
- Supportedcites Zafar et al., 2022 source
Results §3.6 reports reduced serum cholesterol and LDL in probiotic-treated rats on a high-fat, high-cholesterol diet. The Discussion states that reduced weight gain with several strains indicates reduced fat deposition, though deposition was inferred rather than directly measured. No page numbers are available in our copy. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“To fully comprehend its significance, it is crucial to acknowledge that relying solely on high-throughput sequencing to analyze the makeup of gut bacteria is insufficient to conclusively determine whether Lactobacillus can effectively colonize the intestines and exert its beneficial effects (Valenzuela et al., 2018).”
§ Lactiplantibacillus plantarum N4 ameliorates lipid metabolism and gut microbiota structure in high fat diet-fed rats > Discussion
What the sources say
- Partly supportedcites Valenzuela et al., 2018 sourceExperimental — accuracy not yet measured
The Results (page unavailable) say direct MiSeq sequencing and culture-based analysis were complementary, and report that persistence in larvae was checked by culture when bacterial DNA could not be amplified for sequencing. The paper also measures Lactobacillus persistence in zebrafish larvae, but it does not assess whether Lactobacillus exerts beneficial effects; that part of the claim is unsupported. (LLM, conf=0.86)
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Furthermore, it significantly elevated serum HDL-C levels (p < 0.01).”
§ Lactiplantibacillus plantarum N4 ameliorates lipid metabolism and gut microbiota structure in high fat diet-fed rats > Results > Lactiplantibacillus plantarum N4 reduces body weight and lipid levels in hyperlipidemic rats
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
59 more claims
Create a free account to see all 143 claims and every source verdict.
- Probably not a substantial claim. 42
- It may state two separate claims as one. 50
- The quote only partly states this claim. 1
Citations
Cites
Brown and beige fat: Development, function and therapeutic potential
Harms, M., & Seale, P. (2013) · Nature Medicine · doi:10.1038/nm.3361 · Cited by 2,328 · cited 1×
“Activation of PPAR γ has been observed to induce Ucp1 expression, express beige-characterized precursor cells, and facilitate the differentiation of adipocyte subpopulations (Harms and Seale, 2013).”
BackgroundTrefts, E., Gannon, M., & Wasserman, D. H. (2017) · Current Biology · doi:10.1016/j.cub.2017.09.019 · Cited by 1,452
mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation
Zhang, Y., Swanda, R. V., Nie, L., Liu, X., Wang, C., Lee, H., Lei, G., Mao, C., Koppula, P., Cheng, W., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21841-w · Cited by 698
The application of Ferroptosis in diseases
Qiu, Y., Cao, Y., Cao, W., Jia, Y., & Lu, N. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104919 · Cited by 415
Miess, H., Dankworth, B., Gouw, A. M., Rosenfeldt, M., Schmitz, W., Jiang, M., Saunders, B., Howell, M., Downward, J., Felsher, D. W., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0315-z · Cited by 361
Resveratrol-induced gut microbiota reduces obesity in high-fat diet-fed mice
Wang, P., Li, D., Ke, W., Liang, D., Hu, X., & Chen, F. (2020) · International Journal of Obesity · doi:10.1038/s41366-019-0332-1 · Cited by 301
Oxidative stress and metabolic pathologies: from an adipocentric point of view
Le Lay, S., Simard, G., Martinez, M. C., & Andriantsitohaina, R. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/908539 · Cited by 291 · cited 1×
“Numerous scientific investigations have substantiated a robust correlation between hyperlipidemia and oxidative stress, with oxidative stress assuming a pivotal role in the development of metabolic disorders (Le Lay et al., 2014; Okuno et al., 2018; Raut and Khullar, 2023).”
BackgroundStewart, J., McCallin, T., Martinez, J., Chacko, S., & Yusuf, S. (2020) · Pediatrics in Review · doi:10.1542/pir.2019-0053 · Cited by 239
Probiotic Properties of Lactobacillus plantarum RYPR1 from an Indigenous Fermented Beverage Raabadi
Yadav, R., Puniya, A. K., & Shukla, P. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01683 · Cited by 232 · cited 1×
“Sensitivity to each antibiotic was determined according to the guidelines established by the European Food Safety Authority (Yadav et al., 2016).”
MethodXie, N., Cui, Y., Yin, Y.-N., Zhao, X., Yang, J.-W., Wang, Z.-G., Fu, N., Tang, Y., Wang, X.-H., Liu, X.-W., et al. (2011) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-11-53 · Cited by 211
Cited by
Junxi, S. H. E. N., Fang, L., Tan, Z., Xiao, N., & Peng, M. (2024) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.2024-078 · Cited by 25
Gut microbiota: Implications in pathogenesis and therapy to cardiovascular disease (Review)
Li, L., Shaowei, X., Chen, Y., Liu, Y., Shen, D., Yu, X., Wu, Z., Sun, Y., Chen, K., Luo, J., et al. (2024) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2024.12716 · Cited by 16
Long, C., Li, Z., Jiang, L., Yang, X., Deng, S., Jiang, Y., Zhang, B., & Yue, R. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02747-8 · Cited by 16
“Deng et al. reported that Lactiplantibacillus plantarum N4 could regulate gut microbiota diversity in hyperlipidemic rats, significantly reducing hepatic LD accumulation [297].”
Xu, A., Xie, L., Ouyang, Y., Liu, P., Xiao, Y., Wang, Y., Liu, J., Liu, B., Gao, B., & Zhu, D. (2025) · LWT · doi:10.1016/j.lwt.2025.118191 · Cited by 11
Self-citationOuyang, Y., Zou, S., Liu, P., Xie, L., Xiao, Y., Wang, Y., Wu, G., Liu, J., Liu, B., Gao, B., et al. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1664794 · Cited by 9
“Data processing was carried out in accordance with the previously described procedure (Deng et al., 2024).”
Self-citation
Metadata
- Authors
- Deng, M., Zhang, S., Wu, S., Jiang, Q., Teng, W., Luo, T., Ouyang, Y., Liu, J., & Gu, B.
- Affiliations
- Jiangxi Science and Technology Normal University (CN)
- Corresponding author
- Liu, Jiantao
- Gu, Bing
- ORCID
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2024-06-07
- Volume
- 15
- Pages
- 1390293-1390293
- ISSN
- 1664-302X (ISSN-L)
- PMC
- PMC11190066
- OpenAlex
- W4399526818
- Cited by
- 15
- References
- 72
- Citations by year
- 2026: 9 · 2025: 4 · 2024: 2
- FWCI
- 3.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Microbiology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Natural Science Foundation of China (31960469)
- Natural Science Foundation of Jiangxi Province (20224BAB205043)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Nutrition and Physiology
- Keywords
- probiotics, hyperlipidemia, high-fat diet, cholesterol lowering, lipid metabolism, gut microbiota, fecal metabolomics, glutathione metabolism, PPAR signaling, bile secretion, fumaric acid, GABA, hepatic lipid accumulation, functional foods, Sutterella, Bacteroides, Clostridium, Ruminococcus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lactiplantibacillus plantarum N4 ameliorates lipid metabolism and gut microbiota structure in high fat diet-fed rats. https://app.cochat.ai/papers/10.3389/fmicb.2024.1390293
- The paper
- Deng, M., Zhang, S., Wu, S., Jiang, Q., Teng, W., Luo, T., Ouyang, Y., Liu, J., & Gu, B. (2024). Lactiplantibacillus plantarum N4 ameliorates lipid metabolism and gut microbiota structure in high fat diet-fed rats. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2024.1390293
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.